Drugplain

Tetracaine Hydrochloride 5 mg/mL

Tetracaine Hydrochloride · SOLUTION · Somerset Therapeutics, LLC

4 Recalls on Record
Plain English

Tetracaine Hydrochloride is a solution containing tetracaine hydrochloride at 5 mg/mL, taken ophthalmic. Manufactured by Somerset Therapeutics, LLC.

Key Facts

Brand Name
Tetracaine Hydrochloride
Generic Name
Tetracaine Hydrochloride
NDC Code (Product)
70069-597
Manufacturer
Somerset Therapeutics, LLC
Strength
5 mg/mL
Dosage Form
SOLUTION
Route
OPHTHALMIC
Marketing Status
Application #
ANDA217227
Marketing Start
12/23/2024

Recall History

4 Recalls on Record
Class II10/31/2019

Fagron, Inc

Microbial contamination of non-sterile product.

TerminatedVoluntary: Firm initiated
Class II04/13/2022

Mckesson Medical-Surgical Inc. Corporate Office

cGMP deviations: Temperature abuse

TerminatedVoluntary: Firm initiated
Class II07/02/2019

Altaire Pharmaceuticals, Inc.

Lack of Assurance of Sterility

CompletedVoluntary: Firm initiated
Class II07/02/2019

Altaire Pharmaceuticals, Inc.

Lack of Assurance of Sterility

CompletedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

toxic anterior segment syndrome27 reports
nausea15 reports
aqueous fibrin14 reports
inflammation14 reports
syncope14 reports
sudden death13 reports
abdominal discomfort12 reports
muscle spasms11 reports
oropharyngeal pain11 reports
pain10 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Tetracaine Hydrochloride Ophthalmic Solution 0.5% is indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. Tetracaine Hydrochloride Ophthalmic Solution 0.5% is an ester local anesthetic indicated for procedures requiring a rapid and short-acting topical ophthalmic anesthetic. ( 1 )

Dosage & Administration

2 DOSAGE AND ADMINISTRATION One drop topically in the eye(s) as needed. Discard unused portion. ( 2.1 ) 2.1 Topical Administration One drop topically in the eye as needed. Discard unused portion. 2.2 Sterile Field Administration Open package using standard aseptic technique. The DROP‑TAINER ® dispenser may then be allowed to fall upon a sterile surface. The entire outer surface of the DROP‑TAINER ® dispenser and its contents are sterile.

Contraindications

4 CONTRAINDICATIONS None. None ( 4 )

Adverse Reactions

6 ADVERSE REACTIONS The following serious ocular adverse reactions are described elsewhere in the labeling: Corneal injury with Intracameral Use [See Warnings and Precautions (5.1) ] Corneal Toxicity [See Warnings and Precautions (5.2) ] Corneal Injury due to Insensitivity [ See Warnings and Precautions (5.3) ] The following adverse reactions have been identified following use of Tetracaine Hydrochloride Ophthalmic Solution 0.5%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Ocular Adverse Reactions Transient stinging, burning, and conjunctival redness, eye irritation, eye pain, ocular discomfort. Ocular adverse events: stinging, burning, conjunctival redness ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Alcon Laboratories, Inc., at 1-800-757-9195 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Frequently Asked Questions

What is Tetracaine Hydrochloride used for?

Tetracaine Hydrochloride contains Tetracaine Hydrochloride. It is a solution taken ophthalmic. Consult your doctor for specific uses.

Is Tetracaine Hydrochloride a controlled substance?

Tetracaine Hydrochloride is not classified as a controlled substance by the DEA.

What is the generic name for Tetracaine Hydrochloride?

The generic name for Tetracaine Hydrochloride is Tetracaine Hydrochloride. There are no other listed brand versions of Tetracaine Hydrochloride.

What is the NDC code for Tetracaine Hydrochloride 5 mg/mL?

The NDC (National Drug Code) for Tetracaine Hydrochloride 5 mg/mL is 70069-597, listed by Somerset Therapeutics, LLC.